The store will not work correctly when cookies are disabled.
6-(4-Fluorophenyl)-4,5-dihydro-4-(3-nitrophenyl)-2Hindazol-3-ol
ID: ALA2272768
PubChem CID: 71570798
Max Phase: Preclinical
Molecular Formula: C19H14FN3O3
Molecular Weight: 351.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=[N+]([O-])c1cccc(C2CC(c3ccc(F)cc3)=Cc3n[nH]c(O)c32)c1
Standard InChI: InChI=1S/C19H14FN3O3/c20-14-6-4-11(5-7-14)13-9-16(18-17(10-13)21-22-19(18)24)12-2-1-3-15(8-12)23(25)26/h1-8,10,16H,9H2,(H2,21,22,24)
Standard InChI Key: IJNFVVCHJFYBRB-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0825 2.3453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9982 3.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2894 3.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2745 5.2767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9680 6.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3235 5.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3086 3.7509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5651 6.0427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6113 5.4549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5514 7.2426 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 -1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6203 -2.9951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9210 -3.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2184 -2.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2150 -1.4893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9143 -0.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.2590 -3.5870 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 2 0
4 9 1 0
3 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
11 16 1 0
17 18 1 0
17 19 2 0
13 17 1 0
5 11 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
20 25 1 0
23 26 1 0
7 20 1 0
M CHG 2 17 1 18 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.34 | Molecular Weight (Monoisotopic): 351.1019 | AlogP: 4.24 | #Rotatable Bonds: 3 |
Polar Surface Area: 92.05 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.80 | CX Basic pKa: 2.45 | CX LogP: 3.80 | CX LogD: 2.75 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -0.75 |
References
1. Shakil NA, Singh MK, Sathiyendiran M, Kumar J, Padaria JC.. (2013) Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives., 59 [PMID:23229055] [10.1016/j.ejmech.2012.10.038] |